5 Stocks Pushing The Health Services Industry Higher

TheStreet highlights 5 stocks pushing the health services industry higher today.
By TheStreet Wire ,

All three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading up 76 points (0.5%) at 15,300 as of Tuesday, July 9, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 2,101 issues advancing vs. 849 declining with 106 unchanged.

The Health Services industry currently sits down 0.5% versus the S&P 500, which is up 1.2%. A company within the industry that increased today was

Fresenius Medical Care AG & Co. KGaA

(

FMS

), up 1.3%. A company within the industry that fell today was

Abbott Laboratories

(

ABT

), up 0.9%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5.

Cigna

(

CI

) is one of the companies pushing the Health Services industry higher today. As of noon trading, Cigna is up $1.10 (1.5%) to $74.93 on average volume. Thus far, 849,656 shares of Cigna exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $73.84-$74.99 after having opened the day at $74.08 as compared to the previous trading day's close of $73.83.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $21.1 billion and is part of the health care sector. Shares are up 38.3% year to date as of the close of trading on Monday. Currently there are 9 analysts that rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates

Cigna

as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Cigna Ratings Report

now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading,

WellPoint

(

WLP

) is up $1.35 (1.6%) to $84.44 on average volume. Thus far, 968,478 shares of WellPoint exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $83.03-$84.54 after having opened the day at $83.30 as compared to the previous trading day's close of $83.09.

WellPoint, Inc., a health benefits company, through its subsidiaries, offers network-based managed care plans to large and small employer, individual, Medicaid, and senior markets in the United States. The company operates through three segments: Commercial, Consumer, and Other. WellPoint has a market cap of $24.6 billion and is part of the health care sector. Shares are up 36.4% year to date as of the close of trading on Monday. Currently there are 7 analysts that rate WellPoint a buy, 1 analyst rates it a sell, and 10 rate it a hold.

TheStreet Ratings rates

WellPoint

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, increase in net income and attractive valuation levels. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full

WellPoint Ratings Report

now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading,

Thermo Fisher Scientific

(

TMO

) is up $0.80 (0.9%) to $86.74 on light volume. Thus far, 820,370 shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2.9 million shares. The stock has ranged in price between $86.25-$86.98 after having opened the day at $86.85 as compared to the previous trading day's close of $85.94.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $30.7 billion and is part of the health care sector. Shares are up 34.7% year to date as of the close of trading on Monday. Currently there are 11 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates

Thermo Fisher Scientific

as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Thermo Fisher Scientific Ratings Report

now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading,

Express Scripts

(

ESRX

) is up $0.80 (1.3%) to $64.07 on average volume. Thus far, 1.8 million shares of Express Scripts exchanged hands as compared to its average daily volume of 4.8 million shares. The stock has ranged in price between $63.57-$64.08 after having opened the day at $63.65 as compared to the previous trading day's close of $63.27.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $51.5 billion and is part of the health care sector. Shares are up 17.2% year to date as of the close of trading on Monday. Currently there are 14 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates

Express Scripts

as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Express Scripts Ratings Report

now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading,

UnitedHealth Group

(

UNH

) is up $0.36 (0.5%) to $67.92 on average volume. Thus far, 2.2 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 5.4 million shares. The stock has ranged in price between $67.29-$68.45 after having opened the day at $68.02 as compared to the previous trading day's close of $67.56.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $67.5 billion and is part of the health care sector. Shares are up 24.6% year to date as of the close of trading on Monday. Currently there are 15 analysts that rate UnitedHealth Group a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates

UnitedHealth Group

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

UnitedHealth Group Ratings Report

now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

null

Loading ...